Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 2

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Breast 2

Conditions

Breast Neoplasms 36Neoplasms 7Neoplasm Metastasis 7Endometrial Neoplasms 7Ovarian Neoplasms 5Triple Negative Breast Neoplasms 4Breast Diseases 3Brain Neoplasms 3Sarcoma 2Neoplasms by Site 2Meningioma 2Glioblastoma 2Fallopian Tube Neoplasms 2Breast Neoplasms, Male 2Uterine Cervical Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Solid Tumor, Adult 1Sarcoma, Kaposi 1Retinoblastoma 1Recurrent Ovarian High Grade Serous Adenocarcinoma 1Recurrence 1Prostatic Neoplasms 1Pathologic Complete Response 1Osteosarcoma 1Neurofibromatosis 1 1Neoplasm, Residual 1Multiple Myeloma 1Medulloblastoma 1Lymphoma, Non-Hodgkin 1Lung Neoplasms 1

Interventions

ribociclib 2exemestane 2abemaciclib 2Tamoxifen 2Letrozole 2Anastrozole 2palbociclib 1elacestrant 1acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 1Standard of Care 1Practice Guidelines as Topic 1Methods 1Leuprolide 1Interviews as Topic 1Goserelin 1Genetic Counseling 1Educational Status 1Early Intervention, Educational 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recruiting × Breast Neoplasms, Male × abemaciclib × Clear all
NCT05501704 2026-04-30

ETHAN - ET for Male BC

Dana-Farber Cancer Institute

Phase 2 Recruiting
60 enrolled
Breast

Breast Neoplasms, Male

NCT06805812 2025-02-03

PALMARES-2

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

Recruiting
3,500 enrolled
Breast

Breast Diseases, Breast Neoplasms, Neoplasm Metastasis, Breast Neoplasms, Male

Data powered by HemOnc (CC BY 4.0) Colophon âš¡